Literature DB >> 10781898

Regulation of megakaryocytopoiesis in an in vitro stroma model: preferential adhesion of megakaryocytic progenitors and subsequent inhibition of maturation.

S Zweegman1, M A Veenhof, P C Huijgens, G J Schuurhuis, A M Dräger.   

Abstract

OBJECTIVE: Studies of megakaryocytic progenitor cell interactions have focused on single receptor-ligand interactions using isolated components of the extracellular matrix. To approach a physiologic condition, we studied megakaryocytic development of human progenitor cells cultured on two stromal cell lines and on human bone marrow stroma.
MATERIALS AND METHODS: Human CD34(+) cells were cocultured with stromal layers in the presence of thrombopoietin. Megakaryocytes were quantified by monoclonal antibodies against glycoprotein (GP) IIb/IIIa (CD41) and GPIX (CD42a). Megakaryocytic clonogenic capacity (burst-forming unit-megakaryocyte and colony-forming unit-megakaryocyte) was determined using fibrin clot assays.
RESULTS: After 6 days, a higher percentage of megakaryocytes and more megakaryocytic colonies were recovered from the adherent cell fraction compared to the nonadherent cell fraction. In contrast, significantly more granulocytic and erythroid colonies were recovered from the nonadherent cell fraction. Repeated replating of nonadherent cells onto fresh stroma showed a decline in megakaryocytic recovery of the remaining adherent cells, pointing toward selective adhesion of megakaryocytic progenitors. This was supported further by the finding that burst-forming unit and colony-forming unit megakaryocytes were preferentially recovered from the adherent cell fraction at 24 hours. No effect of blocking the beta(1) integrins VLA-4 and VLA-5 on human progenitor cells was observed. A higher expression of CD42a antigen and a higher percentage of morphologically recognizable polyploid megakaryocytes were found when cells were grown in noncontact cultures compared to when grown adhered to stroma.
CONCLUSION: In contrast to granulocytic and erythroid progenitors, both very early and more mature megakaryocytic progenitors are preferentially located in the adherent fraction in an in vitro stromal model, leading to inhibition of maturation of megakaryocytes. This suggests that the presence of stroma components in ex vivo expansion cultures, aimed at preservation and expansion of megakaryocytic progenitors, might be a prerequisite.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10781898     DOI: 10.1016/s0301-472x(00)00128-4

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  5 in total

1.  Heterogeneity amongst splenic stromal cell lines which support dendritic cell hematopoiesis.

Authors:  Geneviève Despars; Helen C O'Neill
Journal:  In Vitro Cell Dev Biol Anim       Date:  2006 Jul-Aug       Impact factor: 2.416

2.  A unique microenvironment in the developing liver supports the expansion of megakaryocyte progenitors.

Authors:  Nathalie Brouard; Camille Jost; Nadine Matthias; Camille Albrecht; Sébastien Egard; Poojabahen Gandhi; Catherine Strassel; Tomoko Inoue; Daisuke Sugiyama; Paul J Simmons; Christian Gachet; Francois Lanza
Journal:  Blood Adv       Date:  2017-09-26

3.  Roles of focal adhesion kinase (FAK) in megakaryopoiesis and platelet function: studies using a megakaryocyte lineage specific FAK knockout.

Authors:  Ian S Hitchcock; Norma E Fox; Nicolas Prévost; Katherine Sear; Sanford J Shattil; Kenneth Kaushansky
Journal:  Blood       Date:  2007-10-09       Impact factor: 22.113

4.  Role for MKL1 in megakaryocytic maturation.

Authors:  Ee-Chun Cheng; Qing Luo; Emanuela M Bruscia; Matthew J Renda; James A Troy; Stephanie A Massaro; David Tuck; Vincent Schulz; Shrikant M Mane; Nancy Berliner; Yi Sun; Stephan W Morris; Caihong Qiu; Diane S Krause
Journal:  Blood       Date:  2009-01-09       Impact factor: 22.113

Review 5.  The role of extracellular matrix stiffness in megakaryocyte and platelet development and function.

Authors:  Orly Leiva; Catherine Leon; Seng Kah Ng; Pierre Mangin; Christian Gachet; Katya Ravid
Journal:  Am J Hematol       Date:  2018-01-12       Impact factor: 10.047

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.